## Note
nid: 1582764819566
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Nivolumab, #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::05_Immune_Checkpoint_Interactions, #AK_Step1_v11::#FirstAid::04_Pathology::03_Neoplasia::05_Immune_Checkpoint_Interactions::Nivolumab, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#SketchyPharm::Miscellaneous_Pharm::AKadds, #AK_Step1_v11::$AnKingAdds::FA2020::Pathology, #AK_Step1_v11::^Other::^HighYield::1-HighYield
markdown: false

### Text
<b>Nivolumab</b> is an <u>anti-checkpoint monoclonal antibody</u>
that binds to {{c1::PD-1}} on <b>T cells</b>

### Extra
<img src="paste-37685c673019b7cc4fd18e8e9f30790aaafb246d.jpg">

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_4.png"></a>
</div>

### Additional Resources


### One by one

